© 2018 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#blood cancer

FDA Approves CAR-T Gene Therapy
How Big Data Is Changing Cancer Research
Blood Cancers 101

Primary Myelofibrosis

Primary myelofibrosis is characterized by the buildup of scar tissue (fibrosis) in the bone marrow, the tissue that produces blood cells.
Red and white blood cells

Drug May Help Prevent Resistance to Toxin-Based Leukemia Therapy

Researchers have been working to develop more targeted, less toxic treatments for childhood B-cell acute lymphoblastic leukemia (ALL).

After Three Cancer Diagnoses, Couple Exchanges Vows

“There’s nothing that we can’t face together. We’ll never walk alone.”

From Teacher to Cancer Caregiver—and Coach

One of the most important things for family and friends to embrace when caregiving is to allow for their own self-care.
Red and white blood cells

A New Study Explores the Relationship Between Precursor Conditions and Multiple Myeloma

Researchers want to understand why some patients develop multiple myeloma while for others the disease progresses slowly, or not at all
Red and white blood cells

Tasigna Can Be Discontinued in Some Patients With Leukemia

Patients whose cancer responds rapidly to nilotinib are more likely to maintain their remission.
Red blood cells

Bluebird CAR-T Therapy Has High Multiple Myeloma Remission Rate

Most Phase I study participants responded to the experimental immunotherapy.
Cancer treatment

Why Are Children More Likely to Get Blood Cancers Than Solid Tumors?

Childhood cancers are often the result of DNA mutations that take place early in life, sometimes even before birth.

Health Disparities May Affect End-of-Life Experiences of Minority Blood Cancer Patients

Minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients

One in Five Caregivers of Bone Marrow Transplant Survivors Report Poor Quality of Life

Largest-ever study IDs risk factors, paves way for interventions to help
Red and white blood cells

Blood Cancers: How Do They Differ in Adults Versus Adolescents?

Much work remains to better understand the underlying biology of blood cancers in adolescents and young adults.
A patient’s T cells arrive at the Novartis manufacturing facility in Morris Plains, where they will be re-engineered to recognize and fight cancer and healthy cells expressing a specific antigen in the patient’s body.

Kymriah CAR-T Therapy Leads to Long-Term Remission in Adults With Lymphoma

Findings from the JULIET trial support expanded Food and Drug Administration approval of customized T cells.
Red and white blood cells

Targeted Therapies Improve Outcomes for People With Chronic Lymphocytic Leukemia

Venclexta combination therapy clears leukemia in blood and bone marrow, recent studies show.
Lymphocytes attacking cancer cells

Lymphoma

Red and white blood cells

Leukemia

Red and white blood cells

FDA Approves First Treatment for Erdheim-Chester Disease

FDA expands approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood.
Advertisement
Treatment News
Features